An innovative medical device is responsible for reducing surgical site infection rates by more than 50 percent and for significantly shortening hospital stays when compared with traditional narcotic pain care according to a chew over presented today at the 47th Annual Interscience Conference on Antimicrobial Agents & Chemotherapy (ICAAC). These results indicate that ON-Q(R) PainBuster with ON-Q SilverSoaker(TM) Antimicrobial Catheter from I-Flow Corporation may have the potential to deliver hospitals billions of dollars if used for post-surgical pain relief across multiple surgeries. ON-Q is the only hurt relief handle to include an antimicrobial catheter and the first and only to document an infection reduction capability. The multi-center infection surveillance study comparing two types of post-surgical pain relief -- the use of ON-Q PainBuster with ON-Q SilverSoaker and local anesthetic versus systemic narcotics -- following colorectal surgeries was conducted at 14 U. S surgical sites. It measured the surgical site infection rates 30 days after surgery and length of be for 289 patients including any hospital re-admissions or other necessary infection treatment after they were released from the hospital. Colorectal surgery was chosen for the study as it is the most infection-prone surgery in most hospitals. Patients were randomized to receive either continuous infusion of local anesthetic using ON-Q or traditional narcotic pain management. Results showed that the ON-Q patients were 55 percent less likely to create a surgical place infection when compared to the hold back assort (6.6 percent versus 14.6 percent; p-value of 0.033). The patient's average length of stay dropped to 6.1 days for ON-Q patients from 8.4 days for the hold back assort a 27 percent reduction (p-value of 0.0003). The co-lead investigators of the study were Dr. Jay Singh of Piedmont Colorectal Associates. Director of Surgical Residency. Piedmont and Associate Professor of Surgery. Emory University in Atlanta and Dr. Alan Thorson. Clinical cerebrate Professor of Surgery and schedule Director of Colon and Rectal Surgery at Creighton University."I undergo used ON-Q for post-surgical hurt relief for hundreds of my patients and undergo seen them undergo significantly less pain a quicker recovery and fewer infections when recuperating from surgery," said Dr. Singh. "I intend to act to use ON-Q as my standard of compassionate post-surgically to provide superior pain relief and to lower the risk of infection for my patients."The Centers for Medicare & Medicaid Services (CMS) recently announced that for discharges occurring on or after October 1. 2008 hospitals will not receive additional payment for patients in which certain conditions were not show on admission such as hospital-acquired infections. CMS reserved the right to add to the enumerate of hospital-acquired infections which may prove in higher costs to hospitals if infection rates are not reduced. Based on this study. ON-Q shows potential to help hospitals hold back costs related to surgical place infections. Using data from the ON-Q Colorectal Infection chew over and a systematic audit published in the American Journal of Infection Control it appears that ON-Q may save thousands of dollars for an average surgical recovery by decreasing the assay of infection length of hospital be and post-discharge complications. If the data is projected across all p ost-surgical situations where the system would be allot potential savings to the healthcare system could be billions of dollars. The unique infection prevention capability of the system is enhanced by the ON-Q SilverSoaker catheter that is treated with an antimicrobial plate agent in nanotechnology create and has been shown in in-vitro testing to be 99.9 percent effective in decreasing bacteria and fungus commonly associated with hospital-acquired infections. plate has desire been known as an antimicrobial agent and is now used in many modern medical devices. In addition when patients are treated with ON-Q they often do not experience the immune-suppressive response of narcotics which can essentially weaken patients and alter it more difficult for their bodies to fight an infection."ON-Q PainBuster with ON-Q SilverSoaker Antimicrobial Catheter is considered the merchandise leader in hurt relief pumps due to its superior hurt relief go of use faster recovery times for patients and antimicrobial benefits," stated Donald M. Earhart. President and CEO of I-Flow Corporation. "We are extremely encouraged about the role ON-Q may now be able to play in infection prevention and surgical place compassionate potentially lowering healthcare be across hospitals and health systems."About ON-QON-Q PainBuster from I-Flow Corporation is the market leader in continuous surgical-site pain relief systems -- commonly known as "hurt pumps" or "hurt relief pumps." It consists of a small balloon pump that holds local anesthetic (a pain-numbing medicine) and delivers it automatically through its proprietary ON-Q SilverSoaker catheter treated with an antimicrobial silver agent to provide even distribution of local anesthesia over a wider area than competitive devices. ON-Q is the only hurt relief handle to consider an antimicrobial catheter and the first and only to enter an infection reduction capability. ON-Q is labeled to significantly reduce hurt exceed than narcotics and to significantly reduce narcotics intake after surgery. ON-Q was upheld as a best practice for post-surgical pain relief and its widespread use was encouraged as part of a in an independent study published in the prestigious Journal of American College of Surgeons. Currently more than 55 studies on the use of ON-Q undergo been completed and published or presented and more investigate is being conducted to investigate the benefits of ON-Q in such areas as infection prevention combination therapies (e g. local anesthetic and antibiotic mixtures a combination of a local anesthetic and an anti-inflammatory) pediatrics and chronic pain. Medicare recognizes ON-Q as a payable covered acquire and therefore medically necessary. To learn more about the benefits of ON-Q visit.
About I-Flow Corporation I-Flow Corporation ( ) designs develops and markets technically advanced low cost medicate delivery systems and services that are redefining the standard of care by providing life enhancing cost effective solutions for pain relief."Safe experience" StatementStatements by the Company in this press channel and in other reports and statements released by the Company are and will be forward-looking in nature and express the affiliate's current opinions about trends and factors that may impact future operating results. Statements that use words such as "may," "will," "should," "believes," "predicts," "estimates," "projects," "anticipates" or "expects" or use similar expressions are intended to identify forward-looking statements. Forward-looking statements are affect to material risks assumptions and uncertainties which could create actual results to differ materially from those currently expected and readers are cautioned not to place undue reliance on these forward-looking statements. object as required by applicable law the affiliate undertakes no obligation to publish revised forward-looking statements to designate the occurrence of unanticipated or subsequent events. Readers are also urged to carefully review and consider the various disclosures made by the affiliate in this touch release that seek to discuss interested.
Forex Groups - Tips on Trading
Related article:
http://www.nanotech-now.com/news.cgi?story_id=25073
comments | Add comment | Report as Spam
|
